April 7 (Bloomberg) -- Shares of the following companies are having unusual moves in U.S. trading. Stock symbols are in parentheses and prices are as of 10:50 a.m. in New York.
Allscripts Healthcare Solutions Inc. (MDRX US) had the second-biggest decline in the Russell 1000 Index, sliding 7.1 percent $20.90. The software maker was cut to “hold” from “buy” at Auriga USA LLC.
Bed Bath & Beyond Inc. (BBBY US) gained 9.3 percent to $53.99 for the biggest rally in the Standard and Poor’s 500 Index. The home furnishings retailer forecast annual earnings of $3.38 to $3.53 a share. That compares with the average analyst projection of $3.33, Bloomberg data show.
Buckle Inc. (BKE US) rose 8.5 percent to $43.98 and climbed to $45.49 earlier, the highest intraday price since 1992. The teen retailer reported March sales at stores open at least one year increased 8.4 percent from a year earlier. Analysts expected a decline of 1.2 percent.
Constellation Brands Inc. (STZ US) rose 4.5 percent to $21.29 for the second-biggest gain in the S&P 500. The world’s largest wine company said that, excluding some items, it expects to earn at least $1.90 a share in fiscal 2012. That beat the average estimate of $1.89 from analysts in a Bloomberg survey.
Costco Wholesale Corp. (COST US) rose 3.4 percent to $77.57, the third-biggest increase in the S&P 500. The largest U.S. warehouse-club chain reported total comparable sales rose 13 percent in March, beating the 7.4 percent estimate.
Immucor Inc. (BLUD US) climbed 5.1 percent to $21 after jumping as much as 7.4 percent, the most intraday since Jan. 7. The maker of products used to screen donated blood reported third-quarter earnings of 32 cents a share, beating the average analyst projection of 26 cents a share, according to data compiled by Bloomberg.
Immunogen Inc. (IMGN US) advanced 21 percent to $11.28 and rallied 26 percent earlier, the most intraday since March 2009. The Waltham, Massachusetts-based drugmaker said that patients treated with T-DM1, which consists of the company’s DM1 cancer cell-killing agent, had a significant improvement in “progression-free survival.”
Lam Research Corp. (LRCX US) slipped the most in the Russell 1000 Index, dropping 7.8 percent to $51.95. The maker of chip-manufacturing equipment may disappoint investors when reporting earnings for the current quarter as demand slows, Citigroup Inc. wrote in a note, in which it added the idea of selling the shares its Top Picks Live! list.
KLA-Tencor Corp. (KLAC US), another semiconductor-equipment maker, declined 4.5 percent to $44.08 for the biggest retreat in the S&P 500.
Movado Group Inc. (MOV US) climbed 9.3 percent to $16.35 and jumped to $17.56 earlier, the highest intraday price since October 2008. The watch and jewelry maker reported fourth-quarter earnings that beat analysts’ estimates and said it will resume paying dividends.
Newmont Mining Corp. (NEM US) rose 3.4 percent to $58.38 and advanced to $58.73 earlier, the highest intraday price since Feb. 24. The largest U.S. gold producer plans to raise annual production of the metal to 7 million ounces by 2017 and link its dividend payment to the average sales price for the metal. The 2017 output target represents an increase of about 35 percent over the company’s 2011 forecast of 5.1 million to 5.3 million ounces.
Pier 1 Imports Inc. (PIR US) rose 7.3 percent to $11.31 and jumped to $11.45 earlier, the highest intraday price since May 2006. The home-furnishings retailer reported fourth-quarter earnings of 48 cents a share, beating the average analyst estimate by 1 cent.
Ruby Tuesday Inc. (RT US) slumped 15 percent to $11.32 after sinking as much as 16 percent, the most intraday since March 2009. The casual-dining chain cut its 2011 earnings forecast to a range of 74 cents to 82 cents a share, from 76 cents to 87 cents a share. That’s below the average analyst projection of 91 cents a share.
TPC Group Inc. (TPCG US) jumped 13 percent to $36.78 and rallied to $37.57 earlier, the highest intraday price since 2004. The maker of petrochemical-derived products had its share-price estimate increased to $42 from $39 at Oppenheimer & Co.
WD-40 Co. (WDFC US) fell 6.3 percent to $40.93 and dropped 10 percent earlier, the most intraday since May 6. The San Diego-based maker of lubricants and hand soap cut its 2011 earnings forecast to a range from $2.23 to $2.35 a share, from $2.25 to $2.40 share. The average analyst forecast was $2.31 a share, Bloomberg data show.
XenoPort Inc. (XNPT US) rallied 59 percent to $10.11 for the biggest gain in the Russell 2000 Index. The drugmaker and GlaxoSmithKline Plc (GSK LN) won U.S. approval for a new treatment for restless legs syndrome after more than a year of delays.
To contact the reporter on this story: Lu Wang in New York at firstname.lastname@example.org.
To contact the editor responsible for this story: Nick Baker at email@example.com.